Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease

This publication has 29 references indexed in Scilit:

• Turning off cortical ensembles stops striatal Up states and elicits phase perturbations in cortical and striatal slow oscillations in rat in vivo
  The Journal of Physiology, 2006
• Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
  British Journal of Pharmacology, 2001
• Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action
  Trends in Neurosciences, 1998
• Modulation of Neurotransmission by Cannabinoids in the Basal Ganglia
  European Journal of Neuroscience, 1997
• 2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
  Biochemical and Biophysical Research Communications, 1995
• Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
  Biochemical Pharmacology, 1995
• The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons
  Life Sciences, 1995
• Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
  Science, 1992
• Neuronal localization of cannabinoid receptors in the basal ganglia of the rat
  Brain Research, 1991
• Striatal inhomogeneities and basal ganglia function
  Movement Disorders, 1986